ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Serous tubal intraepithelial neoplasm (STIC): Follow-up of cases

Serous tubal intraepithelial neoplasm (STIC): Follow-up of cases
Study Number of patients with STIC Positive washings Chemotherapy Recurrence Follow-up
(in months)
Paley et al 2001[1] 2 2 of 2 1 0 36 to 48
Agoff et al 2002/2004[2,3] 3 1 of 3 2 0 36
Leeper et al 2002[4] 2 1 of 2 2 0 8 to 17
Manchanda et al 2011/2012[5,6] 7 3 of 7 0 0 7 to 48
Powell et al 2013[7] 17 3 of 17 4 1 (43 months) 40 to 150
Wethington et al 2013[8] 12 1 of 12 0 0 16 to 44
Conner et al 2014[9] 11 5 of 11 3 1 (48 months) 12 to 96
References:
  1. Paley PJ, Swisher EM, Garcia RL, et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: A case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 2001; 80:176.
  2. Agoff SN, Mendelin JE, Grieco VS, Garcia RL. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: Implications for gross examination, cytology, and clinical follow-up. Am J Surg Pathol 2002; 26:171.
  3. Agoff SN, Garcia RL, Goff B, Swisher E. Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations. Am J Surg Pathol 2004; 28:1112.
  4. Leeper K, Garcia R, Swisher E, et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 2002; 87:52.
  5. Manchanda R, Abdelraheim A, Johnson M, et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG 2011; 118:814.
  6. Manchanda R, Drapkin R, Jacobs I, Menon U. The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecol Oncol 2012; 124:185.
  7. Powell CB, Swisher EM, Cass I, et al. Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol 2013; 129:364.
  8. Wethington SL, Park KJ, Soslow RA, et al. Clinical outcome of isolated serous tubal intraepthelial carcinomas (STIC). Int J Gynecol Cancer 2013; 23:1603.
  9. Conner JR, Meserve E, Pizer E, et al. Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol 2014; 132:280.
Graphic 96540 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟